Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant
COPENHAGEN (Reuters) -Novo Nordisk said on Monday an older oral version of its semaglutide drug fail...
24th November, 2025
COPENHAGEN (Reuters) -Novo Nordisk said on Monday an older oral version of its semaglutide drug fail...
24th November, 2025
By Mrinalika Roy (Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first...
21st November, 2025
(Reuters) -Digital health company Waltz Health said on Friday it has launched a program to offer pop...
21st November, 2025
(Reuters) -The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' heart...
21st November, 2025
LONDON (Reuters) -The UK government on Tuesday urged the competition watchdog to launch an investiga...
18th November, 2025
By Patrick Wingrove (Reuters) -Novo Nordisk said on Monday it has begun selling its popular weight-l...
17th November, 2025
COPENHAGEN (Reuters) -Novo Nordisk has more than enough of its Wegovy weight-loss pills to support a...
17th November, 2025
(Reuters) -British medical products maker Convatec on Thursday forecast double-digit percentage grow...
13th November, 2025
By Jennifer Rigby LONDON (Reuters) -A new antimalarial drug developed by Novartis is as effective as...
12th November, 2025
By Bhanvi Satija LONDON (Reuters) -WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordi...
12th November, 2025
Rising medical insurance premiums are being discussed in many countries, and the middle class often...
12th November, 2025
By Nidal al-Mughrabi CAIRO/GAZA (Reuters) -Fourteen-year-old Mohammed Wael Helles has been waiting f...
12th November, 2025